Automatic Measurement of the Myocardial Interstitium

Weber, 1991, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849 van Hoeven, 1990, A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease, Circulation, 82, 848, 10.1161/01.CIR.82.3.848 Rossi, 1998, Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans, J Hypertens, 16, 1031, 10.1097/00004872-199816070-00018 Beltrami, 1994, Structural basis of end-stage failure in ischemic cardiomyopathy in humans, Circulation, 89, 151, 10.1161/01.CIR.89.1.151 Mewton, 2011, Assessment of myocardial fibrosis with cardiovascular magnetic resonance, J Am Coll Cardiol, 57, 891, 10.1016/j.jacc.2010.11.013 Ugander, 2012, Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology, Eur Heart J, 33, 1268, 10.1093/eurheartj/ehr481 Piechnik, 2013, Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI, J Cardiovasc Magn Reson, 15, 13, 10.1186/1532-429X-15-13 Moon, 2013, Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement, J Cardiovasc Magn Reson, 15, 92, 10.1186/1532-429X-15-92 Wong, 2012, Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality, Circulation, 126, 1206, 10.1161/CIRCULATIONAHA.111.089409 Wong, 2014, Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission, Eur Heart J, 35, 657, 10.1093/eurheartj/eht193 Messroghli, 2004, Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart, Magn Reson Med, 52, 141, 10.1002/mrm.20110 Piechnik, 2010, Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold, J Cardiovasc Magn Reson, 12, 69, 10.1186/1532-429X-12-69 Kellman, 2014, T1-mapping in the heart: accuracy and precision, J Cardiovasc Magn Reson, 16, 2, 10.1186/1532-429X-16-2 Fullerton, 1982, NMR relaxation of protons in tissues and other macromolecular water solutions, Magn Reson Imaging, 1, 209, 10.1016/0730-725X(82)90172-2 Braunschweiger, 1986, The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation, Magn Reson Imaging, 4, 285, 10.1016/0730-725X(86)91038-6 Martin, 1990, Determination of extracellular/intracellular fluid ratios from magnetic resonance images: accuracy, feasibility, and implementation, Magn Reson Med, 15, 58, 10.1002/mrm.1910150107 Lu, 2004, Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla, Magn Reson Med, 52, 679, 10.1002/mrm.20178 Shimada, 2012, In vivo measurement of longitudinal relaxation time of human blood by inversion-recovery fast gradient-echo MR imaging at 3T, Magn Reson Med Sci, 11, 265, 10.2463/mrms.11.265 Li, 2015, Quantitative theory for the longitudinal relaxation time of blood water, Magn Reson Med Spees, 2001, Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T(1), T(2), T*(2), and non-Lorentzian signal behavior, Magn Reson Med, 45, 533, 10.1002/mrm.1072 Elliott, 2008, Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 29, 270, 10.1093/eurheartj/ehm342 Perugini, 2005, Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy, J Am Coll Cardiol, 46, 1076, 10.1016/j.jacc.2005.05.073 Fontana, 2014, Native T1 mapping in transthyretin amyloidosis, J Am Coll Cardiol Img, 7, 157, 10.1016/j.jcmg.2013.10.008 White, 2013, T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique, J Am Coll Cardiol Img, 6, 955, 10.1016/j.jcmg.2013.01.011 Schelbert, 2015, Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage, J Am Heart Assoc, 4, e002613, 10.1161/JAHA.115.002613 Kellman, 2012, Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method, J Cardiovasc Magn Reson, 14, 63, 10.1186/1532-429X-14-63 Kellman, 2012, Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience, J Cardiovasc Magn Reson, 14, 64, 10.1186/1532-429X-14-64 Kramer, 2008, Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols, J Cardiovasc Magn Reson, 10, 35, 10.1186/1532-429X-10-35 White, 2014, Reply: effects of blood T1 on extracellular volume calculation, J Am Coll Cardiol Img, 7, 849, 10.1016/j.jcmg.2014.05.007 Kellman, 2013, T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision, J Cardiovasc Magn Reson, 15, 56, 10.1186/1532-429X-15-56 Xue, 2012, Motion correction for myocardial T1 mapping using image registration with synthetic image estimation, Magn Reson Med, 67, 1644, 10.1002/mrm.23153 Hill, 2009, Evaluation of the performance of the Sysmex XT-2000i Hematology Analyzer with whole bloods stored at room temperature, Lab Med, 40, 709, 10.1309/T0FJYP2RBXEHX4 Schelbert, 2014, Therapeutic targets in heart failure: refocusing on the myocardial interstitium, J Am Coll Cardiol, 63, 2188, 10.1016/j.jacc.2014.01.068 Sado, 2012, Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease, Heart, 98, 1436, 10.1136/heartjnl-2012-302346 Liu, 2013, Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 62, 1280, 10.1016/j.jacc.2013.05.078 Banypersad, 2015, T1 mapping and survival in systemic light-chain amyloidosis, Eur Heart J, 36, 244, 10.1093/eurheartj/ehu444 Thirup, 2003, Haematocrit: within-subject and seasonal variation, Sports Med, 33, 231, 10.2165/00007256-200333030-00005 Roujol, 2014, Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE, Radiology, 272, 683, 10.1148/radiol.14140296 Kramer, 2013, T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy?, J Am Coll Cardiol Img, 6, 532, 10.1016/j.jcmg.2013.02.002 Spottiswoode, 2015, Automated inline extracellular volume (ECV) mapping (abstr), J Cardiovasc Magn Reson, 17, W6, 10.1186/1532-429X-17-S1-W6 Yilmaz, 1990, Determination of dependence of spin-lattice relaxation rate in serum upon concentration of added iron by magnetic resonance imaging, Clin Phys Physiol Meas, 11, 343, 10.1088/0143-0815/11/4/008 Wright, 1991, 1991 I.I. Rabi Award. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T, J Magn Reson Imaging, 1, 275, 10.1002/jmri.1880010303 Silvennoinen, 2003, Effects of hematocrit and oxygen saturation level on blood spin-lattice relaxation, Magn Reson Med, 49, 568, 10.1002/mrm.10370 Liu, 2012, Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials, J Cardiovasc Magn Reson, 14, 90, 10.1186/1532-429X-14-90